www.nature.com/scientificreports
OPEN
Published: xx xx xxxx
Publisher Correction: A new antagonist for CCR4 attenuates allergic lung inflammation in a mouse model of asthma Yang Zhang1,5, Yinfang Wu3, Hui Qi1,6, Junhai Xiao2, Hongwei Gong2,4, Yan Zhang1, Enquan Xu1, Song Li2, Dalong Ma1, Ying Wang1, Wen Li3 & Huahao Shen3 Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-11868-9, published online 08 November 2017 The original version of this Article contained an error in the order of author names, which were incorrectly given as ‘Yang Zhang, Yinfang Wu, Hui Qi, Hongwei Gong, Yan Zhang, Enquan Xu, Song Li, Dalong Ma, Junhai Xiao, Ying Wang, Wen Li & Huahao Shen’. In addition, the version of this Article previously published omitted Junhai Xiao as an equally contributing author. These errors have now been corrected in the HTML and PDF versions of this Article. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2018
1
Department of Immunology, School of Basic Medical Sciences, Key Laboratory of Immunology, Ministry of Health, Peking University Health Science Center, Beijing, 100191, China. 2Laboratory of Computer-Aided Drug Design & Discovery, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, China. 3Department of Respiratory Medicine, the Second Affiliated Hospital School of Medicine of Zhejiang University, Zhejiang University institute of Respiratory Diseases, Hangzhou, 310009, China. 4School of Pharmaceutical Sciences, Jilin University, Changchun, 130021, China. 5Department of Hematology, Peking University First Hospital, Beijing, 100034, China. 6Beijing Children’s Hospital, Capital Medical University, Beijing, 100045, China. Yang Zhang, Yinfang Wu, Hui Qi and Junhai Xiao contributed equally to this work. Correspondence and requests for materials should be addressed to Y.W. (email:
[email protected]) or W.L. (email:
[email protected]) or H.S. (email:
[email protected]) SCIenTIfIC RePorts | (2018) 8:6859 | DOI:10.1038/s41598-018-23185-w
1
